Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease
Not Applicable
- Conditions
- Advanced CancerMetastatic Cancer
- Registration Number
- NCT00792896
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
Family usually had a lot of burden to tell the truth to patients. The purpose of this study is to assess the effect of education materials and family conference for advanced cancer patients and family.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- advanced or metastatic cancer patients
- more than 20 years old
- clear consciousness and be able to communicate
Exclusion Criteria
- refuse to know the statement of himself/herself disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Questionnaires before and 1 week after the intervention
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What psychological mechanisms underlie truth-telling interventions in advanced cancer patient-family communication?
How does structured family conference compare to standard care in improving advanced directive completion rates?
Are there biomarkers associated with patient/family readiness to engage in truth-telling discussions for metastatic cancer?
What adverse effects were observed in NCT00792896's truth-telling intervention for advanced cancer patients?
How do truth-telling interventions in NCT00792896 align with palliative care communication strategies in oncology?
Trial Locations
- Locations (1)
National Taiwan University Hospital
🇨🇳Taipei, Taiwan
National Taiwan University Hospital🇨🇳Taipei, TaiwanWe-Yu Hu, Ph.DPrincipal Investigator